NEI to Host Pioneering Peptide Panel at Grand Opening Wellness Event

December 9, 2025 5:00 AM

NEI to Host Pioneering Peptide Panel at Grand Opening Wellness EventThe Neurodivergent Empowerment Institute (NEI) invites the public and health professionals alike to attend its featured panel discussion on cutting-edge peptide therapy at the Celebrate & Connect Grand Opening Wellness Event on Sunday, December 14, 2025, in St. Petersburg, Florida.This panel, presented by integrative health experts, will dive deep into the science, safety, and...

Read more

BioNxt Advances "Melt in Your Mouth" Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia

December 9, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your Mouth" cladribine formulation, built on the Company's proprietary oral dissolvable film (ODF) drug-delivery system. The technology is designed for rapid, sublingual (under-the-tongue) absorption of medication and aims to improve treatment access and comfort for people living with multiple sclerosis...

Read more

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

December 8, 2025 7:22 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") announced today the results to date of its previously announced offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 (the "4.875% Notes") and 11.00% Senior Secured Notes due 2028 (the "11.00% Notes" and together with the 4.875% Notes, the "Existing Senior Secured Notes") for up to $1.6 billion aggregate principal amount (the "Maximum Notes Amount") of...

Read more

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders

December 8, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Special Meeting of Stockholders held on December 8, 2025 (the "Special Meeting").Three proposals were submitted to and approved by the stockholders of the Company at the Special Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the...

Read more

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

December 8, 2025 4:00 PM

Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the second quarter ended October 31, 2025, on Monday, December 15, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code...

Read more

The Artistry of Modern Dentistry with Dr. Coral Posert and Implant Dentistry Vacaville

December 8, 2025 3:45 PM

At Implant Dentistry Vacaville, Dr. Coral Posert believes that the foundation of exceptional dentistry is listening. Every patient is unique, and understanding their goals, concerns, and expectations allows the practice to deliver results that go beyond function and aesthetics. Whether a patient is seeking cosmetic dentistry, dental implants, Invisalign, Zoom teeth whitening, oral surgery, or emergency care, the team ensures that care is...

Read more

Anatomy Warehouse Expands Hands-On Partners Program with Faculty Edition for Educators

December 8, 2025 11:10 AM

Anatomy Warehouse, a leading distributor of anatomical models and simulation training tools, today announces the launch of Hands-On Partners: Faculty Edition, a new educator-focused track within its growing affiliate network. Building on the success of its original Hands-On Partners program, the Faculty Edition gives instructors, clinicians, and creators a simple way to share trusted anatomical models while earning a five percent (5%) commission...

Read more

Medical Care Technologies (OTC Pink:MDCE) Positions Itself in the Multi-Billion Dollar AI Dermatology Market With Google-Backed Melanoma Detection Technology

December 8, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is thrilled to announce a major technology advancement in the development of its soon-to-launch AI wound and skin monitoring platform. The Company has strategically aligned with Derm Foundation, a Google-backed pretrained dermatology imaging model, enabling the app to rapidly evolve into one of the most accessible early-warning tools for melanoma, infection risks, and chronic wound deterioration...

Read more

AMEEREX Signs MOU to Acquire 45.6 Million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

December 8, 2025 9:25 AM

Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company"), a natural-resources group owned and managed by high-profile Qatari investors, announces that it has signed a Memorandum of Understanding (MoU) to acquire a 100% interest in the Corcoran Canyon Silver-Gold Project in Nye County, Nevada.The NI 43-101 Technical Report for Corcoran Canyon outlines a substantial Inferred Mineral Resource totaling approximately 45.6 million silver-equivalent...

Read more

CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting

December 8, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially best-in-class, anti-CD38 monoclonal antibody, for patients with organ transplant rejection and autoimmune diseases, today announced data presented from its Phase 1 open-label study of CID-103 in adult patients with immune thrombocytopenia (ITP) at the 67th American Society of Hematology Annual Meeting and Exposition on December...

Read more

Dr. Varsha Atuluru Joins Ankle & Foot Centers of America

December 8, 2025 9:00 AM

Fellowship-trained in advanced reconstructive techniques, Dr. Varsha Atuluru brings comprehensive, patient-focused foot and ankle care to Newnan, Fayetteville, and Peachtree City.Ankle & Foot Centers of America is pleased to welcome Dr. Atuluru, a fellowship-trained foot and ankle surgeon, to its expanding team of providers. She will care for patients across the Newnan, Fayetteville, and Peachtree City (PTC) offices, offering both conservative...

Read more

MIRAU Capital Management Named Exclusive Financial Planning Partner for Power Up Nursing's National Network

December 8, 2025 9:00 AM

Power Up Nursing™, a national movement dedicated to nurse well-being, today announced that MIRAU Capital Management has been named its exclusive financial planning partner. Together, they are launching Financial First Aid for Nurses, a campaign to help nurses create "care maps" for their money just as they create care plans for their patients.The initiative will equip nurses, nurse leaders, and healthcare executives with tools to understand the...

Read more

Who Does the Best Liposuction in Las Vegas?

December 8, 2025 9:00 AM

Liposuction has climbed to the top of many cosmetic surgery trend lists. The American Society of Plastic Surgeons reports that liposuction was the most commonly performed cosmetic surgery in the United States in 2022, with more than 325,000 procedures and a 23% increase compared to 2019. Global figures from the International Society of Aesthetic Plastic Surgery show a similar pattern, with over 2.3 million liposuction procedures worldwide and a...

Read more

Europe's Hospitals Can't Cut Off Hacked Vendors Fast Enough, New Cyber Report Warns

December 8, 2025 8:45 AM

Against a backdrop of fresh ransomware and outage concerns across Europe, Black Book Research today announced the release of Europe Cybersecurity in Healthcare 2026: Upstream Vendor, AI, and National Platform Risk under NIS2, GDPR, and the EU AI Act, an industry report designed as a practical "how-to" guide for European boards, ministries, CISOs, and hospital clinical leaders.Based on comprehensive polls of 561 executives, CISOs, and health-IT...

Read more

Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network

December 8, 2025 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has begun the commercial launch of diabetes prescription drug Brenzavvy® to its network of 6,500 independent pharmacies (the "Wellgistics Pharmacy...

Read more

Avant Brands Fully Repays $9.5M Secured Convertible Debenture

December 8, 2025 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced the full repayment of its $9.5 million amended and restated convertible debenture (the "A&R Debenture"). The final payment was completed in November 2025, retiring in full the obligation originally issued in connection with the 2023 acquisition of 3PL Ventures Inc.The successful...

Read more

Nomination Committee Appointed for Spago Nanomedical's Annual General Meeting 2026

December 8, 2025 5:00 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - In accordance with the instructions to the nomination committee resolved by the Annual General Meeting ("AGM"), a nomination committee for the 2026 AGM has been appointed.The nomination committee for the 2026 AGM has been formed based on the largest owners as of September 30, 2025, who wish to participate in the nomination committee. The nomination committee has the following composition, which...

Read more

Monthly Newsletter - November: Momentum, Deliveries, and Continued Expansion

December 8, 2025 4:15 AM

iZafe Group (STO:IZAFE-B) - November marked yet another month of strong progress. New municipal rollouts, additional signed agreements, and continued growing interest all confirm that we are firmly establishing ourselves as one of the most attractive options for safe and digital medication management both in Sweden and across our expanding European markets, where interest is rising notably in the Netherlands. We continue to grow in usage, in...

Read more

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

December 8, 2025 1:20 AM

Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced the closing of its previously reported sale of the Just - Evotec Biologics Toulouse site plus an indefinite technology license to Evotec's continuous manufacturing platform technology to Sandoz AG (SIX:SDZ / OTCQX:SDZNY), effective 05 December 2025. In total, potential payments may exceed US$ 650 m plus royalties on a...

Read more

Umbrella Labs Introduces Research-Use-Only MK-677 Ibutamoren Program To Support High-Rigor Endocrine And Metabolic Bench Science

December 8, 2025 1:10 AM

Umbrella Labs today announced the launch of its research-use-only MK-677 (Ibutamoren, Nutrobal) program, built around a liquid formulation and an accompanying methods framework designed for laboratories that require traceable, assay-ready materials for endocrine and metabolic research. Under this initiative, Umbrella Labs is formalizing a complete workflow for MK-677 that spans sourcing, analytical verification, stability mapping, and...

Read more